Recombinant FN polypeptide, product containing polypeptide and preparation method of product

Through the combination of recombinant fibronectin and nanochitosan, protein nanochitosan particles are prepared, which solves the problems of fibronectin instability and antioxidant side effects, and achieves effective repair of skin photoaging and promoting cell migration.

CN118955687APending Publication Date: 2024-11-15AMBOWWAY BIOTECHNOLOGY (XIAMEN) CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411040177.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing antioxidants are used to prevent the side effects of skin photoaging, and the physical and chemical properties of fibronectin are unstable, limiting its application in skin repair.

Method used

Through the functional domain of fibronectin, a recombinant FN polypeptide was designed and combined with nanochitosan to prepare protein nanochitosan particles, which were used to promote cell migration and healing and exist stably in the skin. Repair photoaging damage.

Benefits of technology

Recombinant FN polypeptide and nanochitosan particles significantly promote skin cell migration and healing, effectively repair photoaging damage, maintain the biological activity of proteins, and the preparation method is simple, suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955687A_ABST
    Figure CN118955687A_ABST
Patent Text Reader

Abstract

The invention discloses a recombinant FN polypeptide, a product containing the polypeptide and a preparation method of the product, and the recombinant FN polypeptide comprises an amino acid sequence as shown in SEQ ID NO: 1 and has the effects of promoting cell migration and accelerating cell scratch healing. Recombinant FN polypeptide and nano chitosan are mixed to prepare protein nano chitosan particles, and when chitosan is a nano material, chitosan can change the form of cuticle and interact with the skin surface to destroy tight combination of cuticle cell thickness through a mouse photoaging animal model, so that the protein nano chitosan particles are formed. Therefore, the recombined FN polypeptide is promoted to retain and permeate in the skin, and the effect of better repairing the photoaging of the skin is achieved. In addition, the chitosan carrier can well maintain the biological activity of the protein, so that the protein can stably exist without caking.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine, and in particular to a recombinant FN polypeptide, a product containing the polypeptide, and a method for preparing the product. Background Art

[0002] The skin is the first line of defense of the human body. The skin is divided into two layers: the epidermis and the dermis. The epidermis is on the surface of the skin and mainly plays a protective role. The dermis has many elastic fibers and collagen fibers, which make the skin more elastic and tough.

[0003] Photoaging is a complex process in which excessive sunlight exposure causes characteristic changes in the skin, mainly manifested as dry skin, sagging, wrinkles, increased or lost pigmentation, and capillary dilation. Photoaging damage mainly includes DNA damage, mitochondrial damage, peroxidation of intracellular biomacromolecules (proteins, phospholipids, etc.) and degradation of the extracellular matrix (collagen, elastic fibers), inflammatory cascades, and immunosuppression. In addition to ultraviolet rays, more and more studies have shown that VL (visible light) and IR (infrared light) can also cause photoaging. In daily life, it is inevitable to be exposed to various types of rays, which will accelerate the photoaging of the skin.

[0004] Currently, oral or topical use of antioxidants is an effective method to prevent skin photoaging damage. Commonly used antioxidants include vitamin E, vitamin C, β-carotene, etc. Retinoic acid is also used to treat skin photoaging, increase the synthesis of collagen fibers, inhibit the appearance of abnormal elastic fibers, block inflammatory responses, and promote the clearance of melanin or melanophages, etc. However, long-term use will produce many side effects.

[0005] Fibronectin (FN) is a macromolecular glycoprotein composed of two almost identical disulfide cross-linked polypeptides with a molecular weight of 220kDa. It contains multiple domains and plays an important role in regulating cell migration, growth and adhesion, regulating body development and wound healing, and promoting tissue repair and regeneration. However, the physical and chemical properties of fibronectin are not very stable, it is easy to change at room temperature and pressure, and it is easy to aggregate, which limits its further development and application.

[0006] Chitosan, also known as deacetylated chitosan, is a natural high molecular weight polysaccharide usually extracted from marine crustaceans. It has the advantages of good biocompatibility, antibacterial repair, moisturizing and water locking. Its macromolecular chain contains a large number of hydrophilic groups such as hydroxyl and amino groups, which give it good water absorption, high hygroscopicity and good surface touch. As a natural cationic polysaccharide, chitosan is very suitable for use in combination with macromolecular proteins to maintain the activity of biological macromolecules. Summary of the invention

[0007] The purpose of the present invention is to provide a recombinant FN polypeptide and a product containing the protein and a method for preparing the protein and the product, so that the recombinant FN polypeptide can exist stably, and the recombinant FN polypeptide and the biomaterial prepared therefrom are applied to repair skin photoaging.

[0008] To achieve the above object, the present invention provides a recombinant FN polypeptide comprising the amino acid sequence shown in SEQ ID NO:1.

[0009] Furthermore, the recombinant FN polypeptide is derived from the functional domain of fibronectin.

[0010] The present invention provides a nucleic acid sequence, which is the nucleic acid sequence of the recombinant FN polypeptide provided by the present invention, and the nucleic acid sequence is the nucleic acid sequence shown in SEQ ID NO:2.

[0011] The present invention provides a recombinant vector, comprising a nucleic acid sequence provided by the present invention containing a nucleic acid sequence shown in SEQ ID NO: 2; preferably, the vector is any one of pET-22b, pET-22b, pGEX, pMAL, pTrcHis, pBAD, and pQE.

[0012] The recombinant FN polypeptide provided by the present invention has the purpose of promoting cell migration and / or accelerating cell scratch healing.

[0013] The present invention provides a biological material, comprising the recombinant FN polypeptide provided by the present invention.

[0014] Furthermore, the biomaterial includes the recombinant FN polypeptide and nano-chitosan mixed to prepare protein nano-chitosan particles; preferably, the particle size of the protein nano-chitosan particles is 60-100 nm.

[0015] The present invention provides a method for preparing a biomaterial, which is used to prepare the biomaterial provided by the present invention, comprising:

[0016] Nano-chitosan and acetic acid are added to ultrapure water to obtain a first solution, the pH is adjusted to acidic, and a filtrate is obtained by filtering. The recombinant FN polypeptide is added to the filtrate to obtain a mixed solution containing protein nano-chitosan particles; the mixed solution is stirred and a sodium tripolyphosphate solution is added dropwise thereto to obtain a second solution; the second solution is centrifuged to obtain a precipitate; the precipitate is blown and resuspended to prepare a biomaterial; preferably, the pH is adjusted to acidic to adjust the pH to 4.5-5.0.

[0017] Furthermore, the mass ratio of the recombinant FN polypeptide, nano-chitosan and sodium tripolyphosphate is 0.5-1.5:5:4.

[0018] The biomaterial of the present invention or the biomaterial obtained by the preparation method of the present invention has the function of repairing photoaging.

[0019] In the present invention, the functional domain of fibronectin is recombined to obtain a recombinant FN polypeptide, the molecular weight of which is only 23.5 kd, which reduces the molecular weight of existing fibronectin while retaining its function of promoting the migration and adhesion of fibroblasts. In the cell scratch experiment, the recombinant FN polypeptide proposed by the present invention has the effect of promoting cell migration and accelerating the healing of cell scratches.

[0020] The recombinant FN polypeptide was mixed with nano-chitosan to prepare protein nano-chitosan particles. Through the mouse photoaging animal model, when chitosan is a nanomaterial, it interacts with the skin surface and destroys the tight binding of stratum corneum cells, thereby promoting the retention and penetration of the recombinant FN polypeptide in the skin, making it have a better effect of repairing skin photoaging. In addition, the chitosan carrier can better maintain the biological activity of the protein, making it stable and not agglomerated.

[0021] The biomaterial of the present invention is prepared by ionic crosslinking of recombinant FN polypeptide and nano-chitosan. This method is purely physical crosslinking, does not contain any organic solvent, is easy to prepare, has low requirements on equipment, and is friendly in preparation conditions without damaging proteins, which is conducive to the large-scale production of the biomaterial. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 This is a schematic diagram of the expression vector plasmid map in Example 1 of the present invention;

[0023] Figure 2 The SDS-PAGE electrophoretogram in Example 1 of the present invention is shown;

[0024] Figure 3 This is a diagram of immunoblotting verification of the His tag antibody in Example 1 of the present invention;

[0025] Figure 4 This is a schematic diagram of a cell scratch experiment in Example 2 of the present invention;

[0026] Figure 5 This is a data analysis diagram of the cell scratch experiment in Example 2 of the present invention;

[0027] Figure 6 It is the crystal violet staining diagram in Example 2 of the present invention;

[0028] Figure 7 This is a particle size characterization diagram of the protein nano-chitosan particle biomaterial in Example 3 of the present invention.

[0029] Figure 8 This is a photo-aged back image of a mouse in Example 4 of the present invention;

[0030] Fig. 9This is a data analysis diagram of the content of MDA, GSH-Px, SOD and Hyp in the depilated surface skin of mice in Example 4 of the present invention;

[0031] Fig.10 This is a Masson staining image of a mouse skin sample in Example 4 of the present invention;

[0032] Fig.11 This is a hematoxylin-eosin staining image of a mouse skin sample in Example 4 of the present invention;

[0033] Fig.12 This is a skin thickness data analysis diagram in Example 4 of the present invention;

[0034] Fig.13 This is a data analysis diagram of skin moisture content in Example 4 of the present invention;

[0035] Fig.14 This is a graph showing the analysis of inflammatory gene expression data of mouse skin samples in Example 4 of the present invention. DETAILED DESCRIPTION

[0036] Embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements with the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, and should not be construed as limitations of the present invention. Those who do not indicate specific techniques or conditions in the embodiments are carried out according to the techniques or conditions described in the literature in this area or according to the product specification. Those who do not indicate the manufacturer of the reagents or instruments used are all conventional products that can be obtained commercially. In the following embodiments, if not clearly stated, "%" refers to weight percentage.

[0037] 1. Solid screening medium: containing 100 μg / ml ampicillin; weigh 10g of tryptone, 5g of yeast extract, 10g of sodium chloride (NaCl), add 15g of agar, add 1000mL of water and stir evenly, sterilize at 121℃ for 20min, place the melted LB solid medium in a 55℃ water bath, and add ampicillin when the temperature of the medium drops to 55℃ (touchable) to prevent the antibiotic from becoming ineffective due to excessive temperature, shake well, and pour the plate for later use.

[0038] 2. Liquid culture medium: containing 100 μg / ml ampicillin; weigh 10 g of tryptone, 5 g of yeast extract, and 10 g of sodium chloride (NaCl), add 1000 mL of water and stir evenly, heat to dissolve and then divide into portions, sterilize at 121°C for 20 min, cool to below 50°C and add ampicillin.

[0039] 3. Vector: any one of pET-22b, pGEX, pMAL, pTrcHis, pBAD, and pQE, purchased from Shanghai Newpu.

[0040] 4. Host cells: E. coli BL21 (DE3) competent cells.

[0041] 5. Pancreatic enzyme containing EDTA: purchased from China Pronose.

[0042] 6. Memα culture medium: purchased from Pronocell, China.

[0043] 7. Fetal bovine serum: purchased from Prosperity, China.

[0044] 8. Sodium tripolyphosphate solution: Add 0.8 mg / ml sodium tripolyphosphate to ultrapure water, stir until the sodium tripolyphosphate is completely dissolved, and filter through a 0.45 μm filter to prepare a sodium tripolyphosphate solution.

[0045] 9. PBS: PBS buffer solution. Weigh 8.0g NaCl, 0.2g KCl, 1.44g Na2HPO4, and 0.24g KH2PO4 and dissolve them in 800mL distilled water. Adjust the solution to 7.4 with HCl, and finally add distilled water to make up to 1L to obtain 0.01M PBS buffer solution.

[0046] 10. The data analysis in the embodiments of the present invention was performed using Image J software. * indicates P < 0.05, *** indicates P < 0.001, **** indicates P < 0.0001, and ns indicates no significant difference.

[0047] The preparation method of the biomaterial in the present invention is as follows:

[0048] Nano-chitosan and acetic acid are added to ultrapure water to obtain a first solution, an alkali solution is added to adjust the first solution to acidity, and a filtrate is obtained by filtering, and a recombinant FN polypeptide is added to the filtrate to obtain a mixed solution containing protein nano-chitosan particles; the mixed solution is stirred, and a sodium tripolyphosphate solution is added dropwise to obtain a second solution; the second solution is centrifuged to obtain a precipitate; and the precipitate is blown and resuspended to prepare a biomaterial.

[0049] Preferably, adjusting the pH to acidic is adjusting the pH to 4.5-5.0.

[0050] Example 1: Preparation of recombinant FN polypeptide

[0051] (1) The nucleic acid encoding the recombinant FN polypeptide SEQ ID NO: 2 is fully synthesized, and the nucleic acid is connected to the vector by double digestion with XbaI / BIpI to obtain a recombinant vector for expressing the recombinant FN polypeptide, which is then transformed into a host cell to obtain a first recombinant. The plasmid map of the vector is shown in FIG. Figure 1 shown.

[0052] (2) Spread the first recombinant on solid screening medium and culture at 37°C overnight to obtain positive clones.

[0053] (3) Inoculate the positive clones into liquid culture medium and culture at 37°C until the OD 600 When the ratio of β-D-β-D-galactoside (IPTG) to β-D-β-D-galactoside (IPTG) was 0.5, the seed solution was prepared. The seed solution was inoculated into the liquid culture medium at a ratio of 1:100 (v / v), and after culturing in a shaking incubator at 37°C for 7 hours, a mutagen with a final concentration of 0.1M was added, and the expression was induced by shaking overnight at 28°C. The bacterial cells obtained by induced expression were collected by centrifugation. The mutagen was isopropylthio-β-D-galactoside (IPTG).

[0054] (4) Resuspend the cells at a ratio of 5 ml of lysis buffer to 1 g of cells, add 100 mM PMSF and ultrasonically disrupt the cells for 40 min. After the cells are completely disrupted, transfer them to a centrifuge tube and centrifuge them at 12,000 rpm for 15 min at 4°C. After centrifugation, retain the first supernatant and filter it using a 0.45 μm filter membrane to obtain a crude protein extract.

[0055] (5) Use a His-tag denaturation-resistant nickel column to collect the protein, wash the impurities with washing solution, and finally use elution solution to collect the target protein solution.

[0056] (6) Add 1% Triton X-114 to the target protein solution, shake well, place at 4°C for 30 minutes, heat in a 37°C water bath for 30 minutes, centrifuge at 12000 rpm for 15 minutes at 37°C, and collect the second supernatant. Then desalt the second supernatant using a G25 dextran gel column, determine the protein concentration using a BCA protein concentration kit, and finally filter the resulting protein solution through a 0.22 μm filter membrane to obtain the recombinant FN polypeptide, package it according to the needs of use, and store it at -20°C.

[0057] The amino acid sequence of the recombinant FN polypeptide of the present invention is shown in SEQ ID NO: 1, and the nucleotide sequence of the gene encoding the recombinant FN polypeptide is shown in SEQ ID NO: 2.

[0058] The recombinant FN polypeptide contains the amino acid sequence shown in SEQ ID NO: 1:

[0059] MTPSQPNSHPIQWNAPQPSHISKYILRWRPKNSVGRWKEATIPGHLNASYTIKGLKPGPFSPLVATSEDVPRDLEVVAVVYEGQLISIQQYGHQEVTRFDFTTTSTSTPVTSNTVTGETTATPTSLLISWDAPAVTVRYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITVYAVTGRGDSPASSKPISINYRTEIDDDDKHHHHHH; SEQ ID NO:1。

[0060] The nucleotide sequence encoding the recombinant FN polypeptide contains the nucleic acid sequence shown in SEQ ID NO:2:

[0061] ATGACACCATCACAGCCCAACAGTCATCCCATACAATGGAATGCCCCGCAACCTTCGCACATCTCGAAGTATATACTTC

[0062] GATGGAGGCCTAAGAACAGTGTGGGACGTTGGAAGGAAGCAACTATTCCAGGACATTTGAATGCTTCTTATACAATTAA

[0063] AGGGCTGAAACCAGGCCCGTTCTCCCCATTAGTAGCAACGTCTGAGGACGTGCCAAGGGATCTGGAAGTTGTGGCTGTA

[0064] GTCTATGAGGGGCAGCTCATCAGCATCCAGCAATATGGACACCAGGAGGTGACCCGTTTCGATTTCACAACCACCTCTA

[0065] CATCTACCCCCGTGACGTCGAACACGGTTACTGGAGAAACTACCGCTACTCCAACATCTCTCCTCATTTCTTGGGACGC

[0066] ACCGGCAGTTACAGTGCGGTATTACCGCATAACATATGGCGAAACTGGAGGTAACTCTCCAGTGCAGGAGTTTACAGTG

[0067] CCCGGGTCGAAGTCTACTGCCACGATTTCGGCCTTAAACCCGGAGTAGATTATACGATCACGGTCTACGCCGTTACGG

[0068] GTCGCGGTGATTCTCCTGCTTCATCGAAACCAATATCAATCAATTATAGAACGGAAATCGACGACGATGATAAGCATCACCACCATCACCACTAA; SEQ ID NO: 2.

[0069] The recombinant FN polypeptide prepared in the above steps was subjected to SDS-PAGE electrophoresis analysis. The electrophoresis detection results are shown in Figure 2 As shown, lane M is a marker, and samples in lanes 1, 2, 3, and 4 are prepared recombinant FN polypeptides, whose bands are around 25 KDa and have high purity and concentration.

[0070] The prepared recombinant FN polypeptide was subjected to a Western blotting experiment, and the purity of the obtained recombinant polypeptide was detected by using His as a tag antibody and HRP goat antibody as a secondary antibody. Figure 3 shown.

[0071] Example 2: Functional verification experiment of recombinant FN polypeptide

[0072] 1. Cell scratch test of recombinant FN polypeptide:

[0073] In this example, L-929 mouse fibroblasts were used to perform a cell scratch experiment to explore the effect of the recombinant FN polypeptide on cell migration. The specific steps are as follows:

[0074] (1) Marking: First, use a marker to mark the back of the six-well plate, drawing 3-5 lines in each well.

[0075] (2) Plating: After adjusting the cell state, the cells are plated. The density of the plating needs to be adjusted appropriately according to the growth characteristics of the cells themselves. For L-929 cells, 6×10 5 cells.

[0076] (3) Scratching: When the cells have spread into a monolayer, use a 10 μL pipette tip close to a ruler to draw a line in the well perpendicular to the horizontal line marked by the marker. Try to ensure that each scratch is consistent. It is best to use the same pipette tip to scratch different wells. When scratching, the pipette tip should be vertical and not tilted. Use a ruler to maintain consistent force and complete the scratching in one go.

[0077] The culture conditions during the scratch test were serum-free, which can reduce the effect of simple cell proliferation on migration. After scratching the surface of the 6-well plate cells with a pipette tip, the non-adherent cells were washed with PBS, and then 10μl of the following concentrations of recombinant FN polypeptide were added according to different experimental groups: 1μg / ml, 5μg / ml, 10μg / ml, 50μg / ml. (At the same time, a control group was set up, and the recombinant FN polypeptide was replaced with an equal volume of PBS).

[0078] (4) Image acquisition: Use a fluorescent inverted microscope to take pictures at different time points to ensure that the scratch is centered. Figure 4 As shown, the dotted line shows the boundary of the scratch; 0 μg / ml FN represents the Control group, and 5 μg / ml FN, 10 μg / ml FN, and 50 μg / ml FN represent experimental groups with recombinant FN polypeptide concentrations of 5 μg / ml, 10 μg / ml, and 50 μg / ml, respectively.

[0079] Image J software was used to analyze the scratch area, with time as the horizontal axis and migration rate as the vertical axis to present the results. Figure 5 As shown, there are 6 data bars at each time point on the horizontal axis, and the concentrations of the recombinant FN polypeptide used are, from left to right, 0 μg / ml, 5 μg / ml, 10 μg / ml, and 50 μg / ml.

[0080] The analysis results of the scratch area using Image J software indicate that the recombinant FN polypeptide provided by the present invention can significantly promote the migration of L-929 mouse fibroblasts and accelerate the healing of scratches. Figure 4 Schematic diagram of the scratch test and Figure 5 From the scratch experiment data analysis chart, it can be seen that the cell scratches in cells treated with different concentrations of recombinant FN polypeptide have different degrees of recovery. Compared with the control group, in which cells were not treated with recombinant FN polypeptide, the area of ​​cell scratches in cells treated with recombinant FN polypeptide was significantly reduced within the same treatment time.

[0081] 2. Cell adhesion assay of recombinant FN polypeptide:

[0082] In this example, L-929 mouse fibroblasts were used to conduct a cell adhesion experiment to explore the adhesion ability of the recombinant FN polypeptide to cells. The specific steps are as follows:

[0083] (1) Coating culture plates: Add 10 μl of the following recombinant FN polypeptide concentrations according to different experimental groups: 1 μg / ml, 5 μg / ml, 10 μg / ml, 50 μg / ml (also set up a control group in which the recombinant FN polypeptide was replaced with an equal volume of PBS); coat the 96-well plate at 4°C overnight.

[0084] (2) BSA immersion: aspirate the coating solution, add 200 μl of heat-denatured 1% BSA (BSA is heat-denatured at high temperature and high pressure after preparation), and incubate the 96-well plate at 37°C for 1 hour.

[0085] (3) Washing with culture medium: Wash the 96-well plate twice with serum-free culture medium.

[0086] (4) Preparation of cell suspension: L-929 cells were digested with trypsin containing EDTA, and then digestion was terminated with serum-containing medium. Finally, the cells were washed and resuspended in serum-free medium.

[0087] (5) Plate: After counting the cell suspension, plate the cell suspension in a pre-treated 96-well plate, with 3-5×10 4 cells.

[0088] (6) Continue culturing: Incubate the 96-well plate in a cell culture incubator for 4 h.

[0089] (7) Wash off non-adherent cells: Wash the cultured 96-well plate three times with PBS.

[0090] (8) Crystal violet staining: Add 1% crystal violet to a 96-well plate and incubate for 20 min, then wash 3-4 times with PBS.

[0091] The stained samples were photographed and observed under a fluorescent inverted microscope. Figure 6 As shown, Figure 6 A is the result of crystal violet staining of cells. Figure 6 B is the analysis result of cell adhesion by Image J software. Figure 6 It can be seen that the adhesion ability of cells treated with different concentrations of recombinant FN polypeptide is different. Compared with the control group in which cells are not treated with recombinant FN polypeptide, cells treated with recombinant FN polypeptide have better adhesion ability.

[0092] Example 3: A method for preparing a biomaterial

[0093] (1) Add nano-chitosan and acetic acid to ultrapure water to obtain a first solution, add 1 mol / L sodium hydroxide to the first solution to adjust the first solution to acidity, pH 4.8, so that the concentration of chitosan in the solution is 1 mg / mL, and the concentration of acetic acid is 2 mg / mL, and stir and heat to 40°C to dissolve the chitosan quickly and completely, and filter through a 0.45 μm filter to obtain a filtrate. Add recombinant FN polypeptide to the filtrate so that the concentration of the recombinant FN polypeptide in the solution is 20 μg / ml, and prepare a mixed solution containing protein nano-chitosan particles, wherein the mass ratio of recombinant FN polypeptide, nano-chitosan, and sodium tripolyphosphate is 1:5:4.

[0094] (2) Stirring the mixed solution, adding 300 ml of a 0.8 mg / mL sodium tripolyphosphate solution dropwise to obtain a second solution, and centrifuging the second solution to obtain a precipitate; specifically, the dropping speed is controlled to 0.8 mL / min, the rotation speed is 750 rpm, and the stirring time is 20 min to obtain the second solution, and then centrifuging the second solution after the reaction is completed at a rotation speed of 40,000 rpm.

[0095] (3) The precipitate was resuspended by blowing with 2 mL of PBS to prepare a dispersion containing protein nano-chitosan particles, which was stored at 4° C. for future use.

[0096] The biomaterial containing protein nano-chitosan particles prepared by the above method was characterized by transmission electron microscopy for its morphology and laser particle size scattering for its particle size. The results are as follows: Figure 7 As shown, Figure 7 A. Figure 7 B and Figure 7 C is the particle size of protein nano-chitosan particles in the dispersion under different magnifications using transmission electron microscopy. Figure 7 D is the particle size of the protein nano-chitosan particles. The average particle size of the protein nano-chitosan particles in Example 3 of the present invention is 72.9 nm. They are well dispersed in the dispersion liquid, have a smooth surface, and have a core-shell structure.

[0097] Example 4: Functional verification of biomaterials

[0098] 1. Experimental sample preparation:

[0099] Female ICR mice (6-8 weeks old) weighing between 20-25 g were selected, a total of 36. All animals were kept in rest for 7 days before the experiment to adapt to the environment. Before starting UV irradiation, an electric shaver was used to remove 2.5×3 cm of hair on the back surface of the mice. 2 To keep the mice’s backs hair-free during the entire experiment, new hair on their backs was removed from time to time using a razor.

[0100] Constructing the photoaging skin animal model: Three UVA lamps (40W, peak emission wavelength of 340nm, irradiance of 388.95uw / cm at 30cm from the UVA light source) were used. 2 ) and a UVB lamp (40W, peak emission wavelength of 313nm, irradiance of 161.5uw / cm at 30cm from the UVB light source) 2 ), place 3 UVA lamps and 1 UVB lamp 30 cm above the homemade irradiation chamber.

[0101] All back skin samples were divided into 4 parts (area 1.0×1.0cm 2 ). They were used for accurate weighing for moisture content test, fixed with paraformaldehyde for at least 24 hours for histopathological test, stored in a -80℃ refrigerator together with RNA later for further RT-PCR verification, and the rest were used for physiological and biochemical analysis of SOD, GSH-Px, MDA, Hyp, etc. (SOD, GSH-Px, MDA, Hyp were detected by kits purchased from Nanjing Jiancheng, namely SOD kit (item number A001-3-2), Hyp kit (item number A030-2-1), MDA kit (item number A003-1-2), GSH-Px kit (item number A005-1-2)).

[0102] The mice were divided into 6 groups, 6 mice in each group (Cs nano is nano chitosan, FN-Cs nano is protein nano chitosan particles):

[0103] (1) Control group: Only the back of hair-depilated mice was treated with PBS.

[0104] (2) Model group: The backs of hairless mice were irradiated with UV light, and the hairless parts of the mice were treated with PBS.

[0105] (3) Vc group: The backs of the hairless mice were irradiated with UV light, and after UV light irradiation, the hairless parts of the mice were treated with a 1 mg / ml Vc solution.

[0106] (4) Cs nano group: The back of the hairless mice was irradiated with UV light, and after UV light irradiation, the hairless part of the mice was treated with Cs nano at a concentration of 0.5 mg / ml.

[0107] (5) FN group: The backs of hairless mice were irradiated with UV light, and after UV light irradiation, the hairless parts of the mice were treated with recombinant FN polypeptide at a concentration of 10 μg / ml.

[0108] (6) FN-Cs nano group: The back of the hairless mice was irradiated with UV light, and after UV light irradiation, the hairless part of the mice was treated with FN-Cs nano at a concentration of 10 μg / ml.

[0109] The mice were then placed in a homemade cage in the center of an ultraviolet irradiation device to expose their back skin. The mice were exposed to mixed light of UVB and UVA for 10 minutes every day for the first 5 days, 20 minutes every day from the 6th to the 10th day, and 30 minutes every day from the 11th to the 40th day. The corresponding reagents were applied to the depilated parts of each group of mice after ultraviolet irradiation.

[0110] 2. Protein nano-chitosan particles repair photoaging verification experiment:

[0111] During the experiment, once blisters and erosions appeared on the back skin of the mice, the irradiation was stopped until the symptoms disappeared and then continued. At the end of the experiment, the back skin of the mice was photographed. Figure 8 As shown, the hairless skin of the six groups of mice was photographed at 10, 20, 30 and 40 days after irradiation to observe the effect of protein nano-chitosan particles in repairing photoaging.

[0112] according to Figure 8 It can be seen that the depilatory surface of mice in the Control group was not damaged when only PBS was applied but not exposed to ultraviolet light. The depilatory surface of mice in the Model group was coated with PBS and exposed to ultraviolet light, and severe skin lesions appeared on the depilatory surface, indicating that the photoaging model was successfully established.

[0113] The mice in the Vc group, Cs nano group and FN group were coated with Vc solution, nano-chitosan and recombinant FN polypeptide respectively after irradiation. Although the degree of skin lesions was slightly improved compared with the Model group, they still had relatively serious skin damage. The mice in the FN-Cs nano group treated with protein nano-chitosan particles had almost no skin lesions after 40 days of irradiation, which proved that the protein nano-chitosan particles obtained in the present invention have a good effect in repairing skin photoaging.

[0114] 3. Physiological and biochemical tests:

[0115] (1) Malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) can comprehensively judge the degree of lipid oxidation in the body and are used to judge the degree of photoaging of mouse skin. The skin samples of the depilated parts of the above six groups of mice were taken, and 0.9% saline was added to make a 10% homogenate. Then, the various physiological and biochemical indicators were measured in strict accordance with the instructions of the kit. The results are as follows: Fig. 9 shown.

[0116] When measuring MDA, the Control group was 4.86±1.00nmol / mgprot. Compared with the Control group, the Model group was 14.62±2.01 (P<0.0001), which was significantly higher than the Control group. The SOD content, GSH-Px content and hydroxyproline (Hyp) content in the Model group were significantly different from those in the Control group, indicating that the photoaging model was successfully established.

[0117] In the MDA test, compared with the Model group, the MDA content of the Vc group was 12.41±1.19nmol / mgprot (P=0.0171), the MDA content of the Cs nano group was 11.08±2.05nmol / mgprot (P<0.0001), and the MDA level of the FN-Cs nano group was 8.37±1.48nmol / mgprot (P<0.0001). The MDA content of the FN-Cs nano group was significantly lower than that of the Model group. It can be seen that compared with the use of Vc solution, recombinant FN polypeptide and chitosan alone, the protein nano-chitosan particles in this application can effectively repair the photoaging of the mouse hair removal surface, and have a good ability to repair photoaging.

[0118] In the GSH-Px detection, the GSH-Px level in the Model group was 100.97±3.11U / mgport, in the Vc group was 103.17±4.13U / mgport, and in the FN group was 100.48±4.15U / mgport. The Cs nano group was 102.50±4.71U / mgport, which was not statistically significant compared with the Model group; the FN-Cs nano group was 112.15±6.35U / mgport (0.0017), which was statistically significant compared with the Model group. Compared with the Model group, Vc group, FN group and Cs nano group, the FN-Cs nano group increased the GSH-Px activity in the skin cells on the depilatory surface of mice, which was closer to the GSH-Px activity in the skin cells on the depilatory surface of the Control group mice that were not photoaged.

[0119] In the SOD experiment, the SOD level of the Model group was 24.62±0.99U / mgport. Compared with the Model group, the SOD level of the Vc group was 29.13±1.87U / mgport (P=0.0003), the SOD level of the Cs nano group was 28.70±2.78U / mgport (P=0.0012), and the SOD level of the FN-Cs nano group was 32.27±2.22U / mgport (P<0.0001). The differences among the three groups were statistically significant, and the SOD content of the FN-Csnano group was the highest.

[0120] Hyp is one of the main components of collagen in the body, and its content is an important indicator of collagen tissue content. The Hyp content of the Control group was 3.68±0.13, and the Hyp content of the Model group was 2.66±0.04 (P<0.0001), both significantly lower than that of the Control group. The Hyp content of mice in the positive group was 2.74±0.14, and the Hyp content of mice in the Cs nano group was 2.56±0.10, which was not statistically significant compared with the Model group. Only the Hyp content of the FN-Cs nano group was higher than that of the Model group.

[0121] By testing the contents of MDA, GSH-Px, SOD and Hyp in the hairless surface skin of the above six groups of mice, it can be found that the protein nano-chitosan particles of the present invention can effectively repair skin photoaging and reduce skin cell damage.

[0122] (2) Tissue section staining: The samples obtained from the depilated skin tissue of mice were fixed with 10% formalin, dehydrated in alcohol, and then embedded in paraffin. The sections were cut into 5 μm thick sections and stained with Masson's trichrome and hematoxylin-eosin (H&E). The results are shown in Table 1. Fig.10 and Fig.11 shown.

[0123] The results of Masson staining showed that the subcutaneous collagen fibers in the Model group were significantly reduced and disordered, and a "fault" appeared between the epidermis and the dermis. The collagen fibers in the Vc group, FN group, and Cs nano group were sparse, not tightly connected, and the collagen bundles were twisted and broken. The FN-Cs nano group significantly improved the reduction of collagen fibers caused by UV exposure, and the structure and density of dermal collagen fibers were almost close to those of the Control group.

[0124] The skin thickness and water content of the samples obtained from the depilated skin tissue of the mice were tested and analyzed by Image J. The results are shown in the figure. Fig.12 and Fig.13 As shown, the FN-Cs nano group significantly improved the increase in skin thickness and decrease in skin water content caused by UV exposure, and the skin thickness and skin water content were almost close to the Control group. The above experimental results show that the protein nano-chitosan particles proposed in the present invention have a good ability to repair photodamage and will not cause hyperplasia on the surface of photodamaged skin.

[0125] (3) Fluorescence quantitative PCR was used to verify the expression of genes related to inflammation. The expression of inflammatory genes was detected using a Roche fluorescence quantitative PCR instrument (Switzerland). The results were as follows: Fig.14 shown.

[0126] There was a significant difference between the Model group and the Control group. The expression of inflammatory genes in the FN-Cs nano group was lower than that in the experimental group and similar to that in the Control group. After ultraviolet irradiation, nuclear factor-κB (NF-κB) was activated, leading to the expression of pro-inflammatory factors such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). Fig.14 As shown, the expression levels of inflammatory factors in each group increased, but the degree of increase was different. The expression of IL-1β, IL-6, and TNF-α in the FN-CS nano group was significantly lower than that in the model group, the positive drug group, and the CS nano group, which was consistent with the lower inflammatory cell infiltration observed in the FN-CS nano group in H&E staining, which once again proved that the protein nano-chitosan particles in the present invention have a good effect in reducing inflammatory response.

[0127] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations on the present invention. A person skilled in the art may change, modify, replace and modify the above embodiments within the scope of the present invention without departing from the principles and intent of the present invention.

Claims

1. A recombinant FN polypeptide, It is characterized in that It comprises the amino acid sequence shown in SEQ ID NO:

1.

2. The recombinant FN polypeptide according to claim 1, It is characterized in that The recombinant FN polypeptide is derived from the functional domain of fibronectin.

3. A nucleic acid sequence, It is characterized in that The nucleic acid sequence of the recombinant FN polypeptide according to claim 1 or 2, wherein the nucleic acid sequence is the nucleic acid sequence shown in SEQ ID NO:

2.

4. A recombinant vector, It is characterized in that The nucleic acid sequence described in claim 3 contains the nucleic acid sequence shown in SEQ ID NO: 2; preferably, the vector is any one of pET-22b, pET-22b, pGEX, pMAL, pTrcHis, pBAD, and pQE.

5. A use of the recombinant FN polypeptide of claim 1 or 2 for promoting cell migration and / or accelerating cell scratch healing.

6. A biomaterial, It is characterized in that It comprises the recombinant FN polypeptide as claimed in claim 1 or 2.

7. The biomaterial according to claim 6, It is characterized in that The biomaterial comprises the recombinant FN polypeptide and nano-chitosan, which are mixed to obtain protein nano-chitosan particles; preferably, the particle size of the protein nano-chitosan particles is 60-100 nm.

8. A method for preparing a biomaterial, It is characterized in that For preparing the biomaterial described in claim 6, comprising: Nano-chitosan and acetic acid are added to ultrapure water to obtain a first solution, the pH is adjusted to acidic, and a filtrate is obtained by filtering. The recombinant FN polypeptide is added to the filtrate to obtain a mixed solution containing protein nano-chitosan particles; the mixed solution is stirred and a sodium tripolyphosphate solution is added dropwise thereto to obtain a second solution; the second solution is centrifuged to obtain a precipitate; the precipitate is blown and resuspended to prepare a biomaterial; preferably, the pH is adjusted to acidic to adjust the pH to 4.5-5.

0.

9. The method for preparing the biomaterial according to claim 8, It is characterized in that The mass ratio of recombinant FN polypeptide, nano-chitosan and sodium tripolyphosphate is 0.5-1.5:5:

4.

10. A biomaterial as claimed in claim 6 or 7 or a biomaterial obtained by the preparation method as claimed in claim 8 or 9 having a photoaging repairing effect.

Citation Information

Patent Citations

  • Transdermal method for loading FN protein by using nano chitosan particles and application

    CN118416201A

  • Recombinant FN polypeptide with effect of promoting cell migration and proliferation

    CN118420746A

  • Injectable FN3-sodium alginate hydrogel as well as preparation method and application thereof

    CN118987334A

  • Nano dressing as well as preparation method and application thereof

    CN118987335A